| 國立成功大學 |
2023 |
Long-term patient-reported donor-site morbidity after free peroneal fasciocutaneous flap in head and neck reconstruction
|
Lee, S.-Y.;Yang, K.-C.;Lin, C.-T.;Ho, Y.-Y.;Chen, L.-W.;Liu, W.-C. |
| 國立成功大學 |
2023 |
Hydrogen detecting characteristics and an improved algorithm for data transmission of a palladium nanoparticle/amorphous InGaZnO thin film based sensor
|
Niu, J.-S.;Chen, P.-L.;Chang, Chang C.-W.;Tsai, J.-H.;Lin, K.-W.;Hsu, W.-C.;Liu, W.-C. |
| 國立成功大學 |
2023 |
A receptor-binding domain-based nanoparticle vaccine elicits durable neutralizing antibody responses against SARS-CoV-2 and variants of concern
|
Lee, I.-J.;Lan, Y.-H.;Wu, P.-Y.;Wu, Y.-W.;Chen, Y.-H.;Tseng, S.-C.;Kuo, T.-J.;Sun, C.-P.;Jan, Jan J.-T.;Ma, H.-H.;Liao, C.-C.;Liang, J.-J.;Ko, H.-Y.;Chang, Chang C.-S.;Liu, W.-C.;Ko, Y.-A.;Chen, Y.-H.;Sie, Z.-L.;Tsung, S.-I.;Lin, Y.-L.;Wang, I.-H.;Tao, M.-H. |
| 國立成功大學 |
2023 |
Ammonia Sensing Performance of an Al-Doped SnO Thin Film Decorated With Platinum Nanoparticles
|
Zhu, B.-X.;Chiu, Chiu C.-C.;Jian, Jian J.-J.;Lin, K.-W.;Hsu, W.-C.;Liu, W.-C. |
| 國立成功大學 |
2023 |
Reduction of pesticides and bacteria on Napa cabbage by ozone microbubble water
|
Chen, H.-L.;Arcega, R.D.;Liao, P.-Y.;Hou, C.-Y.;Liu, W.-C.;Chen, Y.-R.;Wu, J.-S.;Wang, Wang W.-R.;Lin, C.-M. |
| 國立成功大學 |
2023 |
Characterization of microbial contamination of retail washed and unwashed shell eggs in Taiwan
|
Hsu, S.-C.;Chen, H.-L.;Chou, Chou C.-F.;Liu, W.-C.;Wu, C.-T. |
| 國立成功大學 |
2023 |
Comparison of the outcomes of anterolateral thigh flap and peroneal flap in total laryngectomy reconstruction
|
Hsieh, Y.-H.;Chen, I.-W.;Lin, C.-T.;Yang, K.-C.;Liu, W.-C.;Chiu, Chiu C.-C.;Lee, S.-Y.;Chen, L.-W. |
| 臺大學術典藏 |
2022-09-19T03:17:21Z |
Changes of the prescription of hormone therapy in menopausal women: An observational study in Taiwan
|
Huang W.-F.; Tsai Y.-W.; FEI-YUAN HSIAO; Liu W.-C. |
| 臺大學術典藏 |
2022-09-16T08:49:04Z |
Short-course daily isoniazid and rifapentine for latent tuberculosis infection in people living with HIV who received coformulated bictegravir/emtricitabine/tenofovir alafenamide
|
Liou B.-H.; Cheng C.-N.; Lin Y.-T.; Lin Y.-J.; Chuang Y.-C.; Lin K.-Y.; Liu W.-C.; Lin S.-W.; CHING-HUA KUO; Sun H.-Y.; Hung C.-C. |
| 臺大學術典藏 |
2022-09-15T05:50:19Z |
Hepatitis C microelimination among people living with HIV in Taiwan
|
Chen G.-J.; Ho S.-Y.; Su L.-H.; Chang S.-Y.; Hsieh S.-M.; Sheng W.-H.; WANG-DA LIU; Huang Y.-S.; Lin K.-Y.; Chen Y.-T.; Su Y.-C.; Liu W.-C.; Sun H.-Y.; Hung C.-C. |
| 臺大學術典藏 |
2022-09-15T05:50:17Z |
Low-level viraemia and virologic failure among people living with HIV who received maintenance therapy with co-formulated bictegravir, emtricitabine and tenofovir alafenamide versus dolutegravir-based regimens
|
Chen G.-J.; Sun H.-Y.; Chen L.-Y.; Hsieh S.-M.; Sheng W.-H.; WANG-DA LIU; Chuang Y.-C.; Huang Y.-S.; Lin K.-Y.; Wu P.-Y.; Chang H.-Y.; Luo Y.-Z.; Su Y.-C.; Liu W.-C.; Chang S.-F.; Chang S.-Y.; Hung C.-C. |
| 臺大學術典藏 |
2022-09-15T05:50:17Z |
Performance of Hepatitis C Virus (HCV) Core Antigen Assay in the Diagnosis of Recently Acquired HCV Infection among High-Risk Populations
|
Sun H.-Y.; WANG-DA LIU; Wang C.-W.; Wei Y.-J.; Lin K.-Y.; Huang Y.-S.; Su L.-H.; Chen Y.-T.; Liu W.-C.; Su Y.-C.; Chen Y.-W.; Chuang Y.-C.; Lu P.-L.; Hung C.-C.; Yu M.-L. |
| 臺大學術典藏 |
2022-09-15T05:42:31Z |
Non-opioid recreational drug use and a prolonged HIV outbreak among men who have sex with men in Taiwan: An incident case-control study, 2006–2015
|
Lee Y.-C.; Liu W.-C.; Hsieh Y.L.; Wu C.-H.; Wu P.-Y.; Luo Y.-Z.; Yang J.-Y.; Chen Y.-H.; Fang C.-T.; CHIEN-CHING HUNG; Chang S.-C. |
| 臺大學術典藏 |
2022-09-15T05:42:30Z |
Sexually-transmitted hepatitis C virus reinfections among people living with HIV in Taiwan: the emerging role of genotype 6
|
Chen G.-J.; Sun H.-Y.; Chang S.-Y.; Su L.-H.; Chen Y.-T.; Hsieh S.-M.; Liu W.-D.; Sheng W.-H.; Huang Y.-S.; Lin K.-Y.; Su Y.-C.; Liu W.-C.; CHIEN-CHING HUNG |
| 臺大學術典藏 |
2022-09-15T05:42:29Z |
Hepatitis C microelimination among people living with HIV in Taiwan
|
Chen G.-J.; Ho S.-Y.; Su L.-H.; Chang S.-Y.; Hsieh S.-M.; Sheng W.-H.; Liu W.-D.; Huang Y.-S.; Lin K.-Y.; Chen Y.-T.; Su Y.-C.; Liu W.-C.; Sun H.-Y.; CHIEN-CHING HUNG |
| 臺大學術典藏 |
2022-09-15T05:42:27Z |
Incidence of low-level viremia and its impact on virologic failure among people living with HIV-1 who switched to elvitegravir-based antiretroviral therapy
|
Hsu J.-Y.; Sun H.-Y.; Hsieh T.-W.; Chang S.-Y.; Chuang Y.-C.; Huang Y.-S.; Hsiao C.-Y.; Su Y.-C.; Liu W.-C.; Chang S.-F.; CHIEN-CHING HUNG |
| 臺大學術典藏 |
2022-09-15T05:42:26Z |
Three-Stage Pooled Plasma Hepatitis C Virus RNA Testing for the Identification of Acute HCV Infections in At-Risk Populations
|
Sun H.-Y.; Chiang C.; Huang S.-H.; Guo W.-J.; Chuang Y.-C.; Huang Y.-C.; Yang C.-J.; Su L.-H.; Chen Y.-T.; Chen Y.-W.; Hsu F.-C.; Ho S.-Y.; Liu W.-C.; Su Y.-C.; Chang S.-Y.; Hsiao C.-F.; CHIEN-CHING HUNG; Yu M.-L. |
| 臺大學術典藏 |
2022-09-15T05:42:25Z |
Hepatitis C Virus Reinfection in People With HIV in Taiwan After Achieving Sustained Virologic Response With Antiviral Treatment: The RECUR Study
|
Liu C.-H.; Sun H.-Y.; Peng C.-Y.; Hsieh S.-M.; Yang S.-S.; Kao W.-Y.; Shih Y.-L.; Lin C.-L.; Liu C.-J.; Sheng W.-H.; Lo Y.-C.; Liu W.-C.; Wu J.-H.; Su T.-H.; Tseng T.-C.; Chen P.-J.; CHIEN-CHING HUNG; Kao J.-H. |
| 臺大學術典藏 |
2022-09-15T05:42:25Z |
Performance of Hepatitis C Virus (HCV) Core Antigen Assay in the Diagnosis of Recently Acquired HCV Infection among High-Risk Populations
|
Sun H.-Y.; Liu W.-D.; Wang C.-W.; Wei Y.-J.; Lin K.-Y.; Huang Y.-S.; Su L.-H.; Chen Y.-T.; Liu W.-C.; Su Y.-C.; Chen Y.-W.; Chuang Y.-C.; Lu P.-L.; CHIEN-CHING HUNG; Yu M.-L. |
| 臺大學術典藏 |
2022-09-15T05:42:24Z |
Low-level viraemia and virologic failure among people living with HIV who received maintenance therapy with co-formulated bictegravir, emtricitabine and tenofovir alafenamide versus dolutegravir-based regimens
|
Chen G.-J.; Sun H.-Y.; Chen L.-Y.; Hsieh S.-M.; Sheng W.-H.; Liu W.-D.; Chuang Y.-C.; Huang Y.-S.; Lin K.-Y.; Wu P.-Y.; Chang H.-Y.; Luo Y.-Z.; Su Y.-C.; Liu W.-C.; Chang S.-F.; Chang S.-Y.; CHIEN-CHING HUNG |
| 臺大學術典藏 |
2022-09-09T04:21:39Z |
Evolution of estimated glomerular filtration rate in human immunodeficiency virus and hepatitis C virus-coinfected patients receiving sofosbuvir-based direct-acting antivirals and antiretroviral therapy
|
Liu C.-H.; Sun H.-Y.; Hsieh S.-M.; Liu W.-C.; Sheng W.-H.; Liu C.-J.; Su T.-H.; Tseng T.-C.; Chen P.-J.; Hung C.-C.; JIA-HORNG KAO |
| 臺大學術典藏 |
2022-09-09T04:21:16Z |
Hepatitis C Virus Reinfection in People With HIV in Taiwan After Achieving Sustained Virologic Response With Antiviral Treatment: The RECUR Study
|
Liu C.-H.; Sun H.-Y.; Peng C.-Y.; Hsieh S.-M.; Yang S.-S.; Kao W.-Y.; Shih Y.-L.; Lin C.-L.; Liu C.-J.; Sheng W.-H.; Lo Y.-C.; Liu W.-C.; Wu J.-H.; Su T.-H.; Tseng T.-C.; Chen P.-J.; Hung C.-C.; JIA-HORNG KAO |
| 臺大學術典藏 |
2022-09-07T07:41:46Z |
Significant hypercapnia either in CO2-insufflated or air-insufflated colonoscopy under deep sedation
|
Chao I.-F.; HAN-MO CHIU; Liu W.-C.; Liu C.-C.; Wang H.-P.; Cheng Y.-J. |
| 臺大學術典藏 |
2022-09-07T06:39:26Z |
Therapeutic drug monitoring and pharmacogenetic, study of HIV-infected ethnic chinese receiving efavirenz-containing antiretroviral therapy with or without rifampicin-based anti-tuberculous therapy
|
Lee K.-Y.; SHU-WEN LIN; Sun H.-Y.; Kuo C.-H.; Tsai M.-S.; Wu B.-R.; Tang S.-Y.; Liu W.-C.; Chang S.-Y.; Hung C.-C. |
| 臺大學術典藏 |
2022-09-07T06:39:24Z |
Incidence and risk factors of skin rashes and hepatotoxicity in HIV-infected patients receiving nevirapine-containing combination antiretroviral therapy in Taiwan
|
Tseng Y.-T.; Yang C.-J.; Chang S.-Y.; SHU-WEN LIN; Tsai M.-S.; Liu W.-C.; Wu P.-Y.; Su Y.-C.; Luo Y.-Z.; Yang S.-P.; Hung C.-C.; Chang S.-C. |
| 臺大學術典藏 |
2022-09-07T06:39:23Z |
Cholelithiasis and nephrolithiasis in HIV-positive patients in the era of combination antiretroviral therapy
|
Lin K.-Y.; Liao S.-H.; Liu W.-C.; Cheng A.; SHU-WEN LIN; Chang S.-Y.; Tsai M.-S.; Kuo C.-H.; Wu M.-R.; Wang H.-P.; Hung C.-C.; Chang S.-C. |
| 臺大學術典藏 |
2022-09-07T06:39:22Z |
Presence of tablet remnants of nevirapine extended-release in stools and its impact on virological outcome in HIV-1-infected patients: A prospective cohort study
|
Lee Y.-C.; SHU-WEN LIN; Chen M.-Y.; Chang S.-Y.; Kuo C.-H.; Sheng W.-H.; Hsieh S.-M.; Sun H.-Y.; Chang H.-Y.; Wu M.-R.; Liu W.-C.; Wu P.-Y.; Yang S.-P.; Zhang J.-Y.; Su Y.-C.; Luo Y.-Z.; Hung C.-C.; Chang S.-C. |
| 臺大學術典藏 |
2022-09-07T06:39:18Z |
Treatment response to unboosted atazanavir in combination with tenofovir disoproxil fumarate and lamivudine in human immunodeficiency virus-1-infected patients who have achieved virological suppression: A therapeutic drug monitoring and pharmacogenetic study
|
Tsai M.-S.; Chang S.-Y.; SHU-WEN LIN; Kuo C.-H.; Sun H.-Y.; Wu B.-R.; Tang S.-Y.; Liu W.-C.; Su Y.-C.; Hung C.-C.; Chang S.-C. |
| 臺大學術典藏 |
2022-09-07T06:39:12Z |
Effectiveness of half-a-tablet efavirenz plus 2 nucleos(t)ide reverse-transcriptase inhibitors as maintenance therapy with the guidance of therapeutic drug monitoring among virologically suppressed HIV-positive patients: A prospective study
|
Huang S.-H.; SHU-WEN LIN; Chang S.-Y.; Lin Y.-T.; Sun H.-Y.; Liu W.-C.; Su Y.-C.; Hung C.-C.; Chang S.-C. |
| 臺大學術典藏 |
2022-09-07T06:39:07Z |
Impact of Efavirenz Mid-dose Plasma Concentration on Long-Term Weight Change Among Virologically Suppressed People Living With HIV
|
Huang S.-H.; Huang W.-C.; SHU-WEN LIN; Chuang Y.-C.; Sun H.-Y.; Chang S.-Y.; Kuo P.-H.; Wu P.-Y.; Liu W.-C.; Chiang C.; Hung C.-C.; Chang S.-C. |
| 臺大學術典藏 |
2022-09-07T06:39:07Z |
Therapeutic drug monitoring study on the switch from coformulated 600-mg efavirenz, tenofovir disoproxil fumarate, and emtricitabine to coformulated 400-mg efavirenz, tenofovir disoproxil fumarate, and lamivudine among HIV-positive patients with viral suppression
|
Huang W.-C.; Huang C.-K.; Huang S.-H.; SHU-WEN LIN; Ou S.-T.; Chen Y.-T.; Chen Y.-W.; Chang S.-Y.; Liu W.-C.; Sun H.-Y.; Hung C.-C. |
| 臺大學術典藏 |
2022-09-07T06:39:06Z |
Short-course daily isoniazid and rifapentine for latent tuberculosis infection in people living with HIV who received coformulated bictegravir/emtricitabine/tenofovir alafenamide
|
Liou B.-H.; Cheng C.-N.; Lin Y.-T.; Lin Y.-J.; Chuang Y.-C.; Lin K.-Y.; Liu W.-C.; SHU-WEN LIN; Kuo C.-H.; Sun H.-Y.; Hung C.-C. |
| 臺大學術典藏 |
2022-06-20T05:55:19Z |
Recently acquired hepatitis C virus infection among people living with human immunodeficiency virus at a university hospital in Taiwan
|
Huang M.-H.; Sun H.-Y.; Ho S.-Y.; Chang S.-Y.; Hsieh S.-M.; WANG-HUEI SHENG; Chuang Y.-C.; Huang Y.-S.; Su L.-H.; Liu W.-C.; Su Y.-C.; Hung C.-C. |
| 臺大學術典藏 |
2022-06-20T05:55:18Z |
Sexually-transmitted hepatitis C virus reinfections among people living with HIV in Taiwan: the emerging role of genotype 6
|
Chen G.-J.; Sun H.-Y.; Chang S.-Y.; Su L.-H.; Chen Y.-T.; Hsieh S.-M.; Liu W.-D.; WANG-HUEI SHENG; Huang Y.-S.; Lin K.-Y.; Su Y.-C.; Liu W.-C.; Hung C.-C. |
| 臺大學術典藏 |
2022-05-25T06:44:45Z |
Use of dietary supplements containing polyvalent cations and antacids among people with HIV and its impact on viral suppression
|
Peng A.-T.; Huang S.-H.; Sun H.-Y.; Huang Y.-C.; YU-CHUNG CHUANG; Wu P.-Y.; Chen L.-Y.; Chang H.-Y.; Luo Y.-Z.; Liu W.-C.; Kuo H.-Y.; Hung C.-C. |
| 臺大學術典藏 |
2022-05-25T06:44:44Z |
Short-course daily isoniazid and rifapentine for latent tuberculosis infection in people living with HIV who received coformulated bictegravir/emtricitabine/tenofovir alafenamide
|
Liou B.-H.; Cheng C.-N.; Lin Y.-T.; Lin Y.-J.; YU-CHUNG CHUANG; Lin K.-Y.; Liu W.-C.; Lin S.-W.; Kuo C.-H.; Sun H.-Y.; Hung C.-C. |
| 臺大學術典藏 |
2022-05-25T06:44:44Z |
Recently acquired hepatitis C virus infection among people living with human immunodeficiency virus at a university hospital in Taiwan
|
Huang M.-H.; Sun H.-Y.; Ho S.-Y.; Chang S.-Y.; Hsieh S.-M.; Sheng W.-H.; YU-CHUNG CHUANG; Huang Y.-S.; Su L.-H.; Liu W.-C.; Su Y.-C.; Hung C.-C. |
| 臺大學術典藏 |
2022-05-25T06:44:41Z |
Incidence of low-level viremia and its impact on virologic failure among people living with HIV-1 who switched to elvitegravir-based antiretroviral therapy
|
Hsu J.-Y.; Sun H.-Y.; Hsieh T.-W.; Chang S.-Y.; YU-CHUNG CHUANG; Huang Y.-S.; Hsiao C.-Y.; Su Y.-C.; Liu W.-C.; Chang S.-F.; Hung C.-C. |
| 臺大學術典藏 |
2022-05-13T08:04:28Z |
Neutralizing antiinterferon-γ autoantibodies causing disseminated Mycobacterium avium complex infection in an HIV-infected patient on successful combination antiretroviral therapy
|
Wu U.-I.; Hung C.-C.; Chang S.-Y.; Jhong Y.-T.; Sun H.-Y.; JANN-TAY WANG; Hsieh S.-M.; Sheng W.-H.; Liu W.-C.; Chang S.-C.; Chen Y.-C. |
| 臺大學術典藏 |
2022-04-28T12:32:03Z |
Metabolic syndrome among HIV-infected Taiwanese patients in the era of highly active antiretroviral therapy: Prevalence and associated factors
|
Wu P.-Y.; Hung C.-C.; Liu W.-C.; Hsieh C.-Y.; Sun H.-Y.; Lu C.-L.; Wu H.; KUO-LIONG CHIEN |
| 臺大學術典藏 |
2022-04-25T03:56:50Z |
A three-dimensional coupled hydrodynamic-ecological modeling to assess the planktonic biomass in a subalpine lake
|
Liu W.-C;Liu H.-M;Yam R.S.-W.; Liu W.-C; Liu H.-M; Yam R.S.-W.; SAU-WAI YAM |
| 臺大學術典藏 |
2022-04-20T03:56:37Z |
Non-opioid recreational drug use and a prolonged HIV outbreak among men who have sex with men in Taiwan: An incident case-control study, 2006-2015
|
Lee Y.-C.; Liu W.-C.; Hsieh Y.L.; Wu C.-H.; Wu P.-Y.; Luo Y.-Z.; Yang J.-Y.; Chen Y.-H.; CHI-TAI FANG; Hung C.-C.; Chang S.-C. |
| 臺大學術典藏 |
2022-03-04T06:55:01Z |
Cholelithiasis and nephrolithiasis in HIV-positive patients in the era of combination antiretroviral therapy
|
Lin K.-Y.; SIH-HAN LIAO; Liu W.-C.; Cheng A.; Lin S.-W.; Chang S.-Y.; Tsai M.-S.; Kuo C.-H.; Wu M.-R.; Wang H.-P.; Hung C.-C.; Chang S.-C. |
| 臺大學術典藏 |
2022-02-15T05:45:02Z |
High prevalence of sexually transmitted coinfections among at-risk people living with HIV
|
Lin K.-Y.; Sun H.-Y.; Lee T.-F.; Chuang Y.-C.; UN-IN WU; Liu W.-C.; Chang S.-Y.; Chen Y.-J.; Hung C.-C.; Chang S.-C. |
| 臺大學術典藏 |
2022-01-24T09:31:31Z |
Peginterferon plus Ribavirin for HIV-infected Patients with Treatment-Naive Acute or Chronic HCV Infection in Taiwan: A Prospective Cohort Study
|
Liu C.-H.; Sheng W.-H.; Sun H.-Y.; Hsieh S.-M.; Lo Y.-C.; CHUN-JEN LIU; Su T.-H.; Yang H.-C.; Liu W.-C.; Chen P.-J.; Chen D.-S.; Hung C.-C.; Kao J.-H. |
| 臺大學術典藏 |
2022-01-24T09:31:19Z |
Generic velpatasvir plus sofosbuvir for hepatitis C virus infection in patients with or without human immunodeficiency virus coinfection
|
Liu C.-H.; Sun H.-Y.; CHUN-JEN LIU; Sheng W.-H.; Hsieh S.-M.; Lo Y.-C.; Liu W.-C.; Su T.-H.; Yang H.-C.; Hong C.-M.; Tseng T.-C.; Chen P.-J.; Chen D.-S.; Hung C.-C.; Kao J.-H. |
| 臺大學術典藏 |
2022-01-24T09:31:18Z |
Generic sofosbuvir-based interferon-free direct acting antiviral agents for patients with chronic hepatitis C virus infection: a real-world multicenter observational study
|
Liu C.-H.; Huang Y.-J.; Yang S.-S.; Chang C.-H.; Yang S.-S.; Sun H.-Y.; CHUN-JEN LIU; Liu W.-C.; Su T.-H.; Yang H.-C.; Hong C.-M.; Tseng T.-C.; Chen P.-J.; Chen D.-S.; Hung C.-C.; Kao J.-H. |
| 臺大學術典藏 |
2022-01-24T09:30:56Z |
Evolution of estimated glomerular filtration rate in human immunodeficiency virus and hepatitis C virus-coinfected patients receiving sofosbuvir-based direct-acting antivirals and antiretroviral therapy
|
Liu C.-H.; Sun H.-Y.; Hsieh S.-M.; Liu W.-C.; Sheng W.-H.; CHUN-JEN LIU; Su T.-H.; Tseng T.-C.; Chen P.-J.; Hung C.-C.; Kao J.-H. |
| 國立成功大學 |
2022 |
Pd Nanoparticle/Pd/Al2O3Resistive Sensor for Hydrogen Detection in a High-Temperature Environment
|
Niu, J.-S.;Huang, C.-H.;Shao, W.-C.;Tsai, J.-H.;Liu, W.-C. |
| 國立成功大學 |
2022 |
Care cascade of tuberculosis infection treatment for people living with HIV in the era of antiretroviral therapy scale-up
|
Lin, K.-Y.;Yang, C.-J.;Sun, H.-Y.;Lee, Y.-T.;Liou, B.-H.;Hii, I.-M.;Chen, T.-C.;Huang, S.-H.;Lee, C.-Y.;Tsai, C.-S.;Lin, C.-Y.;Liu, C.-E.;Chang, H.-Y.;Cheng, Cheng C.-Y.;Lu, P.-L.;Hung, C.-C.;Huang, Y.-S.;Liu, W.-D.;Chen, G.-J.;Liu, W.-C.;Su, Y.-C.;Wu, P.-Y.;Chen, L.-Y.;Zhang, J.-Y.;Tsai, M.-S.;Lin, C.-C.;Lee, Y.-L.;Chen, Y.-H.;Huang, Y.-C.;Ko, W.-C.;Cheng, S.-H.;Chang, S.-Y.;Wang, N.-C.;Lin, T.-Y.;Lee, Y.-C.;Lin, S.-P.;Hsieh, C.-Y.;Wang, H.-W.;Ho, M.-W.;Hung, T.-C.;Tsai, H.-C.;Lin, H.-H.;Lee, C.-H.;Group, Taiwan HIV Study |
